Market: HKEX |
Currency: HKD
Address: Sinopharm Group Building
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Show more
π SINOPHARM Historical Chart
π Statistics
-
Analyst 1 Year Price Target:
$21.41
-
Upside/Downside from Analyst Target:
13.30%
-
Broker Call:
9
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
2025-10-27
π° Dividend History
Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
2025 |
- |
$0.739000 |
- |
2025-06-16 |
- |
Dividend payout |
Total Amount for 2025: $0.739000 |
2024 |
- |
$0.956000 |
- |
2024-06-17 |
- |
Dividend payout |
Total Amount for 2024: $0.956000 |
2023 |
- |
$0.901099 |
- |
2023-06-19 |
- |
Dividend payout |
Total Amount for 2023: $0.901099 |
2022 |
- |
$0.872000 |
- |
2022-06-27 |
- |
Dividend payout |
Total Amount for 2022: $0.872000 |
2021 |
- |
$0.839416 |
- |
2021-06-15 |
- |
Dividend payout |
Total Amount for 2021: $0.839416 |
π
Earnings & EPS History for SINOPHARM
Date | Reported EPS |
---|
2025-10-27 (estimated upcoming) | - |
2012-10-31 | 0.21 |
2012-04-20 | 0.13 |
π° Related News & Research
-
Sinopharm Group 1H25 Results Miss Forecasts β Revenue Weakness and Margin Pressure Persist Amid Policy Changes 12
August 26, 2025
UOB Kay Hian Date of Report: Tuesday, 26 August 2025 Sinopharm Group Faces Ongoing Policy Headwinds: Margin Pressure May Ease in Second Half 2025 Sinopharm…
-
29 April 2025 Retail Market Monitor β Top Singapore & Hong Kong Stock Insights, iFAST Growth, Sinopharm & CapitaLand Ascott Updates 12224
April 29, 2025
Robust Earnings, Shifting Product Mix and Strategic Repositioning: A Deep Dive into 1Q25 Results Across Asia In todayβs dynamic financial landscape, market watchers and investors…
-
Sinopharm Group (1099 HK): Downgrade Amid Weak Revenue Outlook and Policy Challenges
October 29, 2024
Date of Report: October 29, 2024Broker Name: UOB Kay Hian Company Overview Sinopharm Group (1099 HK) is the largest pharmaceutical distributor in China, operating primarily…
π View more Reports